FANDOM


211702en6_ultratard.pdf(file size: 281 KB, MIME type: application/pdf)

EMEA-European Medicines Agency-Scientific Discussion--Ultratard. This document is used here with permission of EMEA.

Ultratard was a long-acting r-DNA Ultralente insulin made by Novo Nordisk, who sold an identical insulin in North America under the brand name Novolin U. Eli Lilly also made r-DNA Ultralente insulin, calling it Humulin U in North America and Humulin Zn in the UK and other countries.

EMEA is the regulatory agency for medications in the European Union (EU); their responsibilities are comparable to those of the US Food & Drug Administration (FDA).

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeDimensionsUserComment
current02:39, August 24, 2006 (281 KB)We hope (Talk | contribs)EMEA-European Medicines Agency-Scientific Discussion--Ultratard. This document is used here with permission of EMEA. Ultratard was a long-acting r-DNA Ultralente insulin made by Novo Nordisk, who sold an identical insulin in North America under the bran

Ad blocker interference detected!


Wikia is a free-to-use site that makes money from advertising. We have a modified experience for viewers using ad blockers

Wikia is not accessible if you’ve made further modifications. Remove the custom ad blocker rule(s) and the page will load as expected.